Asia Deal Watch: Ambrx, NovoCodex Partner On Second ADC Candidate, For CD70-Positive Cancers

 
• By Ian Haydock, Jung Won Shin, and Joseph Haas
Intravascular non Hodgkins lymphoma - Image
Ambrx, NovoCodex are partnering on an ADC for hematologic cancers including NHL

More from Deals

More from Business